Professional Services Inc. operating as The Medical City is a health institution in the Philippines which maintains a network of hospitals and clinics in the Philippines. The TMC also maintains the Guam Regional Medical City in Guam and a network of clinics in the Gulf states.

During the past decade, The Medical City conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Medical City" #1 sponsor was "Pfizer" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Philippine Neurological Association" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Asan Medical Center" with 1 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical City" #1 collaborator was "Alfasigma S.p.A." with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Baguio General Hospital and Medical Center, Philippines" with 1 trials as a collaborator, "Chong Hua Hospital, Philippines" with 1 trials as a collaborator and "East Avenue Medical Center, Philippines" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "The Medical City" are "Covid19" (2 trials), "Hepatocellular Carcinoma" (2 trials), "Adnexal Mass" (1 trials), "Adult Soft Tissue Sarcoma" (1 trials) and "Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "The Medical City" in a lesser frequency.

Most popular intervention types in "The Medical City" are "Drug" (20 trials), "Device" (5 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "2.0 mg DE-122 Injectable Solution + Lucentis" (1 trials) and "4.0 mg DE-122 Injectable Solution + Lucentis" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Medical City" are 26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Medical City". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in The Medical City, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Medical City, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".